LSE · ABDX.L
Abingdon Health Plc
£0.09-£0.00 (-3.5%)
Abingdon Health Plc’s quoted price sits in the lower half of its reported 52-week range, 33.19% below the high.
Loading market information…
OTC · RXMD · USD
Stock price, earnings
Quote as of Sep 27, 2024, 04:52 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Progressive Care, Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.11% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Progressive Care, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Progressive Care, Inc., primarily operating through its subsidiary Pharmco, LLC, offers a suite of pharmaceutical and healthcare support services across South Florida. The company runs a retail pharmacy with a specialization in anti-retroviral medications and comprehensive patient care management. Its operations also include the sale and rental of durable medical equipment (DME), such as hospital beds, oxygen apparatus, power wheelchairs, and mobility aids. Additionally, it supplies a wide array of prescription pharmaceuticals to long-term care facilities. Beyond these services, Progressive Care develops and implements long-term care solutions for institutional clients, encompassing skilled nursing facilities, assisted living communities, retirement centers, medical offices, and clinics. This involves the procurement, repackaging, and distribution of both prescribed and over-the-counter pharmaceutical products tailored for its long-term care customer base. Further offerings include the computerized maintenance of patient medication histories, third-party billing administration, and expert consultant pharmacist services. These consulting functions involve the evaluation of monthly patient drug therapies, monitoring institutional drug distribution systems, providing home service and maintenance for equipment, facilitating defective product replacements, and offering complimentary home installation and instruction. The company also furnishes data analytics capabilities to assist healthcare organizations. Progressive Care, Inc. was established in 2005 and is headquartered in Hallandale Beach, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£0.09-£0.00 (-3.5%)
Abingdon Health Plc’s quoted price sits in the lower half of its reported 52-week range, 33.19% below the high.
$0.21-$0.04 (-16.39%)
Simply Better Brands Corp.’s quoted price sits in the lower half of its reported 52-week range, 54.04% below the high.
$0.33-$0.03 (-8.71%)
Nurosene Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.73% below the high.
$0.82+$0.78 (+2,173.99%)
Titan Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.25% below the high.
$0.17-$0.03 (-13.04%)
Ceapro Inc.’s quoted price sits in the lower half of its reported 52-week range, 57.39% below the high.
$8.50+$0.50 (+6.25%)
Eiger BioPharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.88% below the high.
$0.22-$0.00 (-0.19%)
Antibe Therapeutics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.19% below the high.
$0.08$0.00 (0.0%)
LexaGene Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.58% below the high.
